FluoGuide A/S (FWB:96X) Financings

FluoGuide A/S

Financings

RaiseDateIn US dollars
Private placement of shares
Closed: SEK 104M raised · SEK 38 a share · Navia Corporate Finance AB +4
Dealers: Navia Corporate Finance AB (co-lead), Redeye AB (co-lead), Translution Capital (co-lead), Navia Corporate Finance (co-lead), Redeye (co-lead)
Buyers: Several of the Company's major and institutional shareholders (expressed interest in participating with approximately SEK 95 million)
Use of proceeds: Phase II trials of FG001 in HGG in the US and in head and neck cancer, CMC and drug manufacturing for phase III HGG trial, and general corporate purposes
Nov 3, 2025US$10.96M

Read by 6ix AI from the company's releases